U.S., June 10 -- ClinicalTrials.gov registry received information related to the study (NCT07635043) titled 'Efficacy of Topical Tapinarof Versus Betamethasone in the Treatment of Plaque Psoriasis' on June 03.
Brief Summary: To assess the effectiveness of topical tapinarof to topical betamethasone in patients with mild to moderate plaque psoriasis presenting to tertiary care hospital in Islamabad
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition:
Psoriasis (PsO)
Intervention:
DRUG: Betamethasone Dipropionate 0.05% Cream
Topical betamethasone dipropionate 0.05% cream once daily applied to affected plaque psoriasis lesions twice daily for up to 4 weeks
DRUG: Tapinarof Cream 1%
Topical tapinarof 1% cream applied once dai...